Hematology Medical Education
  • Forum
  • Webinars
    • upcoming
    • previous
  • Congresses
    • EHA 2022 Insider
    • ASH 2021 INSIDER
    • EHA 2021 Virtual
  • Series
    • Myeloma Connect
    • Challenges in CLL
    • Challenges in NHL
  • Podcasts
    • Challenges in CLL
    • Challenges in NHL - mantle cell lymphoma
    • Challenges in NHL - Waldenström’s macroglobulinemia
  • Faculty
    • Scientific Committee
    • Christian Buske
    • Michel Delforge
    • Paolo Ghia
    • Faculty
    • Othman Al-Sawaf
    • Hervé Avet-Loiseau
    • Arjun Balar
    • Panagiotis Baliakas
    • Jacqueline Barrientos
    • Yelak Biru
    • Francesc Bosch
    • Lars Bullinger
    • Jan Burger
    • Christian Buske
    • Elias Campo
    • José Carda
    • Michele Cavo
    • Ajai Chari
    • Solène Clavreul
    • Ruth Clifford
    • Adam Cohen
    • Gordon Cook
    • Charles Craddock
    • Florence Cymbalista
    • Faith Davies
    • Michel Delforge
    • Meletios Dimopoulos
    • Niels van de Donk
    • Peter Dreger
    • Hermann Einsele
    • Toby Eyre
    • Thierry Facon
    • Carlos Fernández de Larrea
    • Robin Foà
    • George Follows
    • Marianna Fontana
    • Gianluca Gaidano
    • Jaime Gállego Pérez-Larraya
    • Ramon Garcia-Sanz
    • Francesca Gay
    • Paolo Ghia
    • Irene Ghobrial
    • Maria Gomes da Silva
    • John Gribben
    • Georg Hess
    • Peter Hillmen
    • Graham Jackson
    • Ulrich Jäger
    • Carl June
    • Lionel Karlin
    • Efstathios Kastritis
    • Arnon Kater
    • Feraz Khan
    • Brian Koffman
    • Shaji Kumar
    • Alessandra Larocca
    • Steven Le Gouill
    • Véronique Leblond
    • Xavier Leleu
    • Georg Lenz
    • Yi Lin
    • Teresa López-Fernández
    • Stefano Luminari
    • Thomas Lund
    • Alexander Lyon
    • Deepu Madduri
    • Ahmed Magdy
    • Salomon Manier
    • Ana Marín Niebla
    • Joaquin Martinez-Lopez
    • María Victoria Mateos
    • Ulf-Henrik Mellqvist
    • Joseph Mikhael
    • Paolo Milani
    • Roberto Mina
    • Monique Minnema
    • Mohamad Mohty
    • Philippe Moreau
    • Carol Moreno
    • Talha Munir
    • Hareth Nahi
    • Fadi Nasr
    • Carsten Utoft Niemann
    • Inger Nijhof
    • Mario Nuvolone
    • Susan O’Brien
    • Enrique M Ocio
    • Gert Ossenkoppele
    • Roger Owen
    • Bruno Paiva
    • Giovanni Palladini
    • Charlotte Pawlyn
    • Uwe Platzbecker
    • Rakesh Popat
    • Christiane Pott
    • Vadim Ptushkin
    • Noemi Puig
    • Noopur Raje
    • Karthik Ramasamy
    • Andrew Rawstron
    • Gail Roboz
    • Paula Rodriguez Otero
    • Richard Rosenquist
    • Davide Rossi
    • Simon Rule
    • Jesús San Miguel
    • Valeria Santini
    • Pablo Sarobe
    • Lydia Scarfò
    • Fredrik Schjesvold
    • Emma Searle
    • Pieter Sonneveld
    • Paolo Sportoletti
    • Kostas Stamatopoulos
    • Stephan Stilgenbauer
    • Catherine Thieblemont
    • Max Topp
    • Steve Treon
    • Jon Ukropec
    • Saad Zafar Usmani
    • Adriano Venditti
    • Martin Vogel
    • Ashutosh Wechalekar
    • Katja Weisel
    • William Wierda
    • Agnieszka Wierzbowska
    • Kwee Yong
    • Elena Zamagni
    • Sonja Zweegman
Log in
  • All
  • CLL
  • NHL
  • Amyloidosis
  • NDMM
  • RRMM
  • Other
MRD - What will change in the next year?
5 July 2022 - 45 Minutes

MRD - What will change in the next year?

Multiple Myeloma~myelomaconnect~NDMM~RRMM

more info...

Faculty

Mohamad Mohty

Mohamad Mohty

Fredrik Schjesvold

Fredrik Schjesvold
Play now
EM-93560
Highlights from EHA 2022: Expert insights and clinical implications for the management of patients with multiple myeloma
22 June 2022 - 64 Minutes

Highlights from EHA 2022: Expert insights and clinical implications for the management of patients with multiple myeloma

EHA2022~Multiple Myeloma~NDMM~RRMM

more info...

Faculty

María Victoria Mateos

María Victoria Mateos

Saad Zafar Usmani

Saad Zafar Usmani

Niels van de Donk

Niels van de Donk
Play now
EM-93557
Challenges in CLL: how does the data from EHA 2022 inform key management questions?
21 June 2022 - 63 Minutes

Challenges in CLL: how does the data from EHA 2022 inform key management questions?

challengesincll~CLL~EHA2022

more info...

Faculty

John Gribben

John Gribben

Paolo Ghia

Paolo Ghia
Play now
EM-78442
Challenges in NHL: how does the data from EHA 2022 inform key management questions?
20 June 2022 - 1 Hours

Challenges in NHL: how does the data from EHA 2022 inform key management questions?

challengesinnhl~EHA2022~NHL

more info...

Faculty

Georg Hess

Georg Hess

Christian Buske

Christian Buske
Play now
EM-78670
Challenges in NHL: managing WM-associated complications: a case study-based discussion
31 May 2022 - 51 Minutes

Challenges in NHL: managing WM-associated complications: a case study-based discussion

challengesinnhl~NHL

more info...

Faculty

Christian Buske

Christian Buske

Véronique Leblond

Véronique Leblond

Roger Owen

Roger Owen
Play now
EM-78665
Bispecific antibodies: raising new horizons for RRMM?
19 May 2022 - 47 Minutes

Bispecific antibodies: raising new horizons for RRMM?

myelomaconnect~RRMM

more info...

Faculty

María Victoria Mateos

María Victoria Mateos

Niels van de Donk

Niels van de Donk

Ajai Chari

Ajai Chari
Play now
EM-88730
Challenges in CLL: What does the future hold - are we approaching cure in CLL?
17 May 2022 - 46 Minutes

Challenges in CLL: What does the future hold - are we approaching cure in CLL?

challengesincll~CLL

more info...

Faculty

John Gribben

John Gribben

Stephan Stilgenbauer

Stephan Stilgenbauer
Play now
EM-78439
Practical considerations around CAR T-cell therapies for patients with multiple myeloma
12 May 2022 - 48 Minutes

Practical considerations around CAR T-cell therapies for patients with multiple myeloma

MM~Multiple Myeloma~myelomaconnect~RRMM

more info...

Faculty

Michel Delforge

Michel Delforge

Paula Rodriguez Otero

Paula Rodriguez Otero

Max Topp

Max Topp
Play now
EM-78417
Bridging the gap between patient and clinician perspectives in myeloma care
10 May 2022 - 46 Minutes

Bridging the gap between patient and clinician perspectives in myeloma care

MM~Multiple Myeloma~myelomaconnect~NDMM~RRMM

more info...

Faculty

Mohamad Mohty

Mohamad Mohty

Solène Clavreul

Solène Clavreul
Play now
EM-78406
Challenges in CLL: Where are we with MRD assessment?
5 May 2022 - 46 Minutes

Challenges in CLL: Where are we with MRD assessment?

challengesincll~CLL

more info...

Faculty

Paolo Ghia

Paolo Ghia

Peter Hillmen

Peter Hillmen
Play now
EM-78437
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
hme webinar
  • Webinars
  • Faculty
  • Scientific Committee
  • Register
  • About HME
  • Support
  • Legal Disclaimer

© Janssen Pharmaceutica NV 2016 Turnhoutseweg 30, B-2340 Beerse — Belgium - All rights reserved

The views expressed within are those of the individual faculty members and do not necessarily reflect the view of Janssen, Pharmaceutical Companies of Johnson and Johnson.

The program and the content of the presentations is owned by the Scientific Third Party Committee and the respective faculty members and may include discussions on off label data of products and therapies.

This site is managed in accordance with Belgian Law, and is published by Janssen Pharmaceutica NV, who is solely responsible for its management. The site is intended for healthcare professionals from Europe, Middle East and Africa. Your use of this site implies your tacit agreement with the application of Belgian and European legislation and with our Privacy Policy.

Privacy Policy - Cookie Policy

CP-155330 - Date of preparation: May 2020